Jillian Jernigan
Advanced Practice Midwife · Milton, FLNPI 1902382468
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,657 and has fallen 95.0% since, to $132 in 2024. Among advanced practice midwife clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$745
- Almatica Pharma LLC$457
- Astellas Pharma US Inc$443
- Novo Nordisk$375
- Axsome Therapeutics, Inc.$372
- Bayer$265
- plus $3K from 42 others
What the payments were for
- Food & beverage$5,77794%
- Education$3586%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,135 in reported general payments places this provider in the 95th percentile of 579 advanced practice midwife providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $20,362 |
| OzempicSemaglutide | 21 | $20,229 |
| Estradiol | 14 | $915 |
| Diclofenac Sodium | 17 | $472 |
| Rosuvastatin Calcium | 29 | $427 |
| Omeprazole | 24 | $409 |
| Ondansetron OdtOndansetron | 12 | $346 |
| Tizanidine Hcl | 16 | $338 |
| Duloxetine Hcl | 17 | $328 |
| Gabapentin | 18 | $276 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 23 | $248 |
| Ondansetron Hcl | 14 | $222 |
| Metoprolol Succinate | 11 | $216 |
| Fluconazole | 14 | $198 |
| Pantoprazole Sodium | 11 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $263 | $20,36219 claims |
| Novo NordiskOzempic | $375 | $20,22921 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $16618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 579 advanced practice midwife providers in Florida.
Other advanced practice midwife in Milton
- Laura RussellBrandon$118K
- Renita GreenTampa$7K
- Jessica BrumleyTampa$5K
- Cristina PalermitiZephyrhills$5K
- Ilona BlumbergBoynton Beach$4K
- Jacinta FeldmanDeland$3K
- Erin FinchLake Mary$3K
- Kristin NoblesOcala$3K
- Susan McCormickSarasota$3K
- Adrienne BradleyBoca Raton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.